Clinical Trials in Portland

Showing 501-520 of 4,842 trials

Rate of Progression in USH2A-related Retinal Degeneration

NCT03146078

The overall goal of this project funded by the Foundation Fighting Blindness is to characterize the natural history of disease progression in patients with USH2A related retinal degeneration associated with congenital hearing loss (Usher syndrome type 2a) or non-syndromic retinitis pigmentosa (RP39). RUSH2A Extension Study: The purpose of this addendum is to extend RUSH2A to 7- and 9-year visits, with the goal to use longer term data to further develop and support early candidate endpoints as possible clinical trial outcomes.

Usher Syndrome, Type 2ARetinitis Pigmentosa 39

Jaeb Center for Health Research127 participantsStarted Aug 2017

San Francisco, California, United States • Gainesville, Florida, United States • Baltimore, Maryland, United States +11 more locations

RECRUITING< 1 mile

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

NCT05334069

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.

Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAnn Arbor Stage I Lymphoma+59 more

Alliance for Clinical Trials in Oncology2,000 participantsStarted Aug 2022

Anchorage, Alaska, United States • Anchorage, Alaska, United States • Anchorage, Alaska, United States +737 more locations

Rate of Progression in USH2A-related Retinal Degeneration

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Find Trials by Condition in Portland

A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2)

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

A Weight Loss Study Evaluating Subcutaneous Treatment With AZD9550 and AZD6234 in Combination Against Placebo or Each of the Drugs Alone

Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)

Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826)

Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung

A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors

PO vs IV Antibiotics for the Treatment of Infected Nonunion of Fractures After Fixation

A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)

Aventus Thrombectomy System Pulmonary Embolism Clinical Study

A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency Diseases

HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs

A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Anticancer Activity of GSK4524101 Alone or With Niraparib in Participants With Solid Tumors

Micra AV Transcatheter Pacing System Post-Approval Registry

International Registry Study of Neutral Lipid Storage Disease (NLSD) / Triglyceride Deposit Cardiomyovasculopathy (TGCV) and Related Diseases

Global Open-Label Extension Study of Del-desiran for the Treatment of DM1

Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study